PRODUCT DESCRIPTION:

Cefpodoxime is an advanced third-generation cephalosporin antibiotic designed for oral administration.

It exhibits broad-spectrum bactericidal activity by inhibiting bacterial cell wall synthesis and is stable against many β-lactamase–producing strains, making it a potent agent against both Gram-positive and Gram-negative bacteria.

It is well-absorbed from the GI tract and demonstrates excellent clinical efficacy in the treatment of respiratory, skin, urinary, and ENT infections.

Cefpodoxime Tablets are preferred for their safety profile, rapid onset, and convenient oral dosing, especially in outpatient and step-down therapy settings.

Formulation & Presentation:

• Dosage Form: Tablets
• Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
• Available Strengths:
  • Cefpodoxime Tablets 200 MG
  • Cefpodoxime Tablets 500 MG
• Route of Administration: Oral (As per physician’s discretion or therapeutic indication)

Therapeutic Indications:

• Community-acquired Pneumonia
• Acute Tonsillitis & Pharyngitis
• Sinusitis
• Otitis Media
• Urinary Tract Infections
• Skin & Soft Tissue Infections
• Gonorrhea (uncomplicated)
• Typhoid Fever
• Lower Respiratory Tract Infections (including bronchitis)

Side Effects:

• COMMON:
  • Nausea
  • Diarrhea
  • Abdominal discomfort
  • Headache
  • Mild rash or pruritus
• SERIOUS (RARE):
  • Hypersensitivity reactions including anaphylaxis
  • Clostridioides difficile–associated diarrhea
  • Hepatotoxicity
  • Stevens-Johnson Syndrome
  • Blood dyscrasias (e.g., neutropenia, eosinophilia)
• PRECAUTIONS:
  • Caution in patients allergic to cephalosporins or penicillins
  • Dose adjustment may be required in renal impairment
  • Not recommended for infants under 2 months of age
  • Use during pregnancy only if clearly needed
  • Monitor liver enzymes during long-term therapy